Bernhardt (Bernie) Zeiher, Md, Fccp, Facp Email and Phone Number
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp work email
- Valid
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp personal email
- Valid
With over 20 years of experience in the pharmaceutical industry, I am passionate about addressing unmet patients’ needs in under-served and serious diseases. During my career, I have participated in the development and approval of 15 products. As the Chief Medical Officer at Astellas and now as a strategic advisor to pharmaceutical industry clients, I strive to create a culture of empowerment and accountability, encourage diversity and inclusion, and foster talent. This enables teams to deliver for patients and society. What excites me every day is the opportunity to do good for others and make a profound difference in patients’ lives. Specialties: Strategy | Governance | Drug Development | Clinical development | Medical Affairs | Critical Care | Oncology | Immunology | Pain | Infectious Disease | Transplant | Small Molecules | Gene Therapy | Cell Therapy | Protocol design | Phase 1 | Phase 2 | Phase 3 | Phase 4 | FDA Advisory Committee | EMA | PMDA
Abeona Therapeutics
View- Website:
- abeonatherapeutics.com
- Employees:
- 51
-
Member Board Of DirectorsAbeona Therapeutics 2024 - PresentCleveland, Oh, UsI serve on the Board of Abeona Therapeutics (NASDAQ: ABEO), a biopharmaceutical company pursuing the development of cell and gene therapies for people impacted by serious diseases. Leveraging my deep experience in drug development and regulatory affairs, I am supporting management in advancement of Abeona's pipeline. I am also a member of the Science and Technology Committee.
-
Member Board Of DirectorsAmylyx Pharmaceuticals 2024 - PresentCambridge, Ma, UsI serve on the Board of Amylyx Pharmaceuticals (NASDAQ: AMLX), a biopharmaceutical company pursuing the development of treatment options for those living with neurodegenerative diseases. Leveraging my deep experience in drug development and regulatory affairs, I am supporting management in advancement of Amylyx's pipeline which primarily targets neuronal cell death. I also chair the Science and Technology Committee and am a member of the Nominating and Corporate Governance Committee. -
Member Board Of DirectorsEntrada Therapeutics 2023 - PresentBoston, Ma, UsI serve on the Board of Entrada Therapeutics (NASDAQ: TRDA), a biopharmaceutical company innovating to transform the treatment of devastating diseases through intracellular therapeutics. In addition to serving on the Compensation Committee, I am leveraging my deep experience in drug development and regulatory affairs, I am supporting management in advancing Entrada’s novel Endosomal Escape Vehicle (EEV™) platform. -
Strategic AdvisorSelf Employed 2022 - PresentSatellite Beach, Florida, UsLeveraging my expertise in the development of biopharmaceutical products across a wide range of therapy areas, I advise biotechnology companies either as interim CMO, strategic consultant, or board member. -
Chief Medical OfficerAstellas Pharma 2019 - 2022I led Astellas’ global organization of 2,750 responsible for early and late-stage development, medical affairs, regulatory affairs, pharmacovigilance, quality assurance, strategy, and operations. I presided over a period of historic R&D productivity at Astellas, delivering 6 product approvals in major markets. The team also progressed 2 other products through pivotal trials. As a result, new product revenue sustained top line performance and offset the impact of divestitures and patent expirations. I reported to the CEO and routinely interacted with buy-side and sell-side analysts. -
Chief Medical Officer And President, DevelopmentAstellas Pharma 2018 - 2019
-
President, Global DevelopmentAstellas Pharma 2015 - 2018In this role, I led a global organization of 850 responsible for early and late-stage development across all therapeutic areas and geographies. My focus in this role was to enhance Astellas’ development capabilities and I oversaw global initiatives that fostered talent development, strengthened governance, adopted new technologies, and streamlined operations. We also progressed 6 late-stage programs that are now approved or under regulatory review. I reported to the Chief Medical Officer.
-
Evp, Therapy Area Head For Immunology, Infectious Disease, Transplant, Cns, PainAstellas Pharma 2014 - 2015I led TA strategy and pipeline delivery for the immunology, infectious disease, transplant, CNS, and pain portfolios. I also led the Development Operations group and Clinical Pharmacology team supporting the entire portfolio. One of our biggest achievements was earning FDA approval and 12 years of market exclusivity for Cresemba®, which was awarded both an orphan designation and a Qualified Infectious Disease Product (QIDP) designation. I led the overall program, as well as NDA preparation, and an FDA advisory committee presentation.
-
Svp, Therapeutic Area Head For Immunology, Infectious Disease, And TransplantAstellas Pharma 2012 - 2014In this role, I led a global team of 20 physicians and project team leaders responsible for therapy area strategy and pipeline delivery for the immunology, infectious disease, and transplant portfolios. I redirected portfolio strategy away from Astellas’ long-term specialty in transplant to focus on areas with greater unmet need, including autoimmune disease.
-
Vice President, Therapeutic Area Leader For Inflammation, Immunology And Infectious DiseasesAstellas Pharma 2010 - 2012I led a team of 10 project team leaders responsible for TA strategy and pipeline delivery for inflammation, immunology, and infectious disease. We secured EU approval of Vibativ® for hospital-acquired pneumonia and gained FDA agreement on the pediatric program for Mycamine®.
-
Member Board Of DirectorsTranscelerate Biopharma Inc. 2014 - 2022Conshohocken, Pennsylvania, UsTransCelerate Biopharma is a non-profit organization consisting of 20 member companies. As an elected board member representing Astellas, I helped to prioritize and oversee implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines. -
Member Board Of DirectorsBiotechnology Innovation Organization 2019 - 2021Washington, Dc, UsBIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. As Astellas' representative on the board, I helped to prioritize and influence policies in support of the BIO mission which is to be the champion of biotechnology and the advocate for our member organizations—both large and small. -
Advisor, Biomedical Advisory CommitteePhrma 2014 - 2019Washington, District Of Columbia, Us -
Vice President, Inflammation Disease Area LeadPfizer 2009 - 2010New York, New York, UsIn this role I led a team of 25 physicians and project team leaders responsible for development and medical affairs for the late-phase inflammation and immunology portfolio that included Xeljanz® and Enbrel®. Following Pfizer’s acquisition of Wyeth, and all the attendant disruption, I sustained progress on the combined organization’s pipeline. -
Executive Director, Inflammation And Pain Clinical DevelopmentPfizer 2006 - 2009New York, New York, Us
-
Senior Director, Inflammation And Pain Early Clinical DevelopmentPfizer 2005 - 2006New York, New York, Us
-
Medical DirectorEli Lilly And Company 2002 - 2005Indianapolis, Indiana, UsIn this role, I was involved in early stage development of Inflammation and Immunology drug candidates, and late-stage development of Effient® (prasugrel). -
Head, Critical Care Clinical ResearchEli Lilly And Company 2001 - 2002Indianapolis, Indiana, UsIn this role I led 2 large multinational Phase 2 programs in critical care, one in acute lung injury and another in sepsis.
-
Clinical Research PhysicianEli Lilly And Company 2000 - 2001Indianapolis, Indiana, Us
-
Associate Medical DirectorMerck 1998 - 2000
-
Pulmonary & Critical Care Staff PhysicianRespiratory & Critical Care Consultants, Pc 1996 - 1998
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp Skills
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp Education Details
-
Case Western Reserve University School Of MedicineUniversity Hospitals Of Cleveland Internal Medicine Residency And Chief Residency -
University Of Iowa Roy J. And Lucille A. Carver College Of MedicineUniversity Of Iowa Hospitals And Clinics Pulmonary And Critical Care Fellowship
-
Case Western Reserve University School Of MedicineMedicine
-
The University Of ToledoGeneral
Frequently Asked Questions about Bernhardt (Bernie) Zeiher, Md, Fccp, Facp
What company does Bernhardt (Bernie) Zeiher, Md, Fccp, Facp work for?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp works for Abeona Therapeutics
What is Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's role at the current company?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's current role is Board Member | Strategic Advisor | Physician Executive | Former Chief Medical Officer | Biopharmaceutical Industry Expert.
What is Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's email address?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's email address is be****@****las.com
What schools did Bernhardt (Bernie) Zeiher, Md, Fccp, Facp attend?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp attended Case Western Reserve University School Of Medicine, University Of Iowa Roy J. And Lucille A. Carver College Of Medicine, Case Western Reserve University School Of Medicine, The University Of Toledo.
What skills is Bernhardt (Bernie) Zeiher, Md, Fccp, Facp known for?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp has skills like Clinical Development, Immunology, Pharmaceutical Industry, Biotechnology, Infectious Diseases, Drug Development, Inflammation, Clinical Trials, Ctms, Oncology, Medical Writing, Pain Management.
Who are Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's colleagues?
Bernhardt (Bernie) Zeiher, Md, Fccp, Facp's colleagues are Olga Kourennaia, Matthew Davis, Dagmar Ostermann-Held, Mary Steben, Maggie C., Kayla Staeble, Shrm-Cp, Donald Wuchterl.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial